Rachel Tsunemoto Hislop
Direttore/Membro del Consiglio presso Abilita Therapeutics, Inc.
Profilo
Rachel Tsunemoto Hislop is currently working as a Director at Abilita Therapeutics, Inc. and as a Principal at Two Bear Capital Operations LLC since 2020.
She completed her undergraduate degree from Massachusetts Institute of Technology.
Posizioni attive di Rachel Tsunemoto Hislop
| Società | Posizione | Inizio |
|---|---|---|
Two Bear Capital Operations LLC
 Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital Operations LLC (Two Bear Capital) is venture capital firm founded in 2019 by Mike Goguen. The firm is headquartered in Whitefish, Montana. | Investitore di Private Equity | 01/01/2020 |
Abilita Therapeutics, Inc.
 Abilita Therapeutics, Inc. BiotechnologyHealth Technology Abilita Therapeutics, Inc. is a biotechnology company that focuses on discovering and developing drugs that target challenging human membrane proteins with high medical impact, such as GPCRs, ion channels, and transporters. The company is based in San Diego, CA. The company's internal drug discovery pipeline is focused on treating cancer and chronic pain. Abilita Bios EMP™ platform fuels research collaborations with pharmaceutical and biotech partners. The company was founded in 2014 by Mauro Mileni, who has been the CEO since 2014. | Direttore/Membro del Consiglio | - |
Formazione di Rachel Tsunemoto Hislop
| Massachusetts Institute of Technology | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Abilita Therapeutics, Inc.
Abilita Therapeutics, Inc. BiotechnologyHealth Technology Abilita Therapeutics, Inc. is a biotechnology company that focuses on discovering and developing drugs that target challenging human membrane proteins with high medical impact, such as GPCRs, ion channels, and transporters. The company is based in San Diego, CA. The company's internal drug discovery pipeline is focused on treating cancer and chronic pain. Abilita Bios EMP™ platform fuels research collaborations with pharmaceutical and biotech partners. The company was founded in 2014 by Mauro Mileni, who has been the CEO since 2014. | Health Technology |
Two Bear Capital Operations LLC
Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital Operations LLC (Two Bear Capital) is venture capital firm founded in 2019 by Mike Goguen. The firm is headquartered in Whitefish, Montana. | Finance |
- Borsa valori
- Insiders
- Rachel Tsunemoto Hislop
